Johns Hopkins
Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens.
US, Canadian Researchers Partner to ID Biomarkers Predictive of Pancreatic Cancer Treatment
The project will involve molecular profiling of patients in a randomized trial and creating patient-derived organoids for personalized drug screening.
A Johns Hopkins-based team said a panel of bispecific antibodies could be developed to target a range of common cancer driver mutations.
John Hopkins, Akoya Biosciences Ink Deal to Advance New Immunotherapy Biomarkers
The partners will use Akoya's multiplex immunofluorescence platform for spatial phenotyping and JHU's AstroPath platform to identify predictive signatures.
Increased incidental detection of clonal hematopoiesis and new considerations for mutations in myelodysplastic precursors herald improved precision medicine strategies.